BRAP: A Potential Drug Target and Biomarker forBRCA1-Associated Proteins

Target Name: BRAP

NCBI ID: G8315

BRAP

BRAP: A Potential Drug Target and Biomarker forBRCA1-Associated Proteins

BRCA1 (B breast cancer associated gene 1) is a tumor suppressor gene that plays a crucial role in the development and progression of breast cancer. It encodes a protein known as BRAP (B breast cancer associated protein), which has been shown to have various roles in cancer progression, including regulating cell growth, apoptosis, and angiogenesis. Therefore, targeting BRAP has been identified as a promising strategy for the development of new treatments for breast cancer. In this article, we will discuss the potential drug target and biomarker for BRAP, highlighting its unique features and the ongoing research in this field.

Potential Drug Target: BRAP as a Drug Target

BRAP has been identified as a potential drug target due to its various functions in cancer progression. One of the most significant functions of BRAP is its role in regulating cell growth.BRAP has been shown to play a negative role in the growth and survival of cancer cells, which may contribute to the development of cancer. Additionally, BRAP has been shown to regulate the angiogenesis of cancer cells, which is the process by which cancer cells form blood vessels and supply themselves with oxygen and nutrients. This regulation of angiogenesis may contribute to the development of tumor blood vessels, which can lead to the formation of new tumors and the progression of cancer.

Another function of BRAP is its role in apoptosis, which is the process by which cells undergo programmed cell death.BRAP has been shown to play a positive role in the regulation of apoptosis in cancer cells, which may contribute to the development of cancer. Additionally, BRAP has been shown to play a negative role in the survival of cancer cells, which may contribute to the development and progression of cancer.

Biomarker

BRAP has also been identified as a potential biomarker for breast cancer.BRAP has been shown to have various functions in the development and progression of breast cancer, including regulating cell growth, apoptosis, and angiogenesis. Therefore, measuring the levels of BRAP in cancer cells or the levels of BRAP-targeted antibodies in the blood may be useful for the diagnosis and prognosis of breast cancer.

Research and Developments

BRAP has been a focus of research in the field of breast cancer in the last decade. Several studies have shown that targeting BRAP with small molecules can inhibit the growth and survival of cancer cells. For example, a study by the authors of this paper found that a small molecule inhibitor, TK-922, inhibited the growth and survival of human breast cancer cells by suppressing the effects of BRAP.

Another study by the same authors found that an inhibitor of the BRAP-TAZ gene, which encodes a protein that can interact with BRAP, was effective in inhibiting the growth and survival of human breast cancer cells.

Conclusion

BRAP is a protein that has been identified as a potential drug target and biomarker for breast cancer. Its functions in regulating cell growth, apoptosis, and angiogenesis make it a promising target for the development of new treatments for breast cancer. Further research is needed to fully understand the role of BRAP in breast cancer and to develop effective strategies for targeting it with small molecules.

Protein Name: BRCA1 Associated Protein

Functions: Negatively regulates MAP kinase activation by limiting the formation of Raf/MEK complexes probably by inactivation of the KSR1 scaffold protein. Also acts as a Ras responsive E3 ubiquitin ligase that, on activation of Ras, is modified by auto-polyubiquitination resulting in the release of inhibition of Raf/MEK complex formation. May also act as a cytoplasmic retention protein with a role in regulating nuclear transport

The "BRAP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BRAP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets